6.50
-0.14
(-2.11%)
At close: January 31 at 9:54:01 PM GMT+1
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-28,684.00
-32,270.00
-26,685.00
-19,874.00
-12,901.00
Investing Cash Flow
17,357.00
19,578.00
-20,417.00
-2,324.00
-173.00
Financing Cash Flow
17,680.00
813.00
-557.00
105,361.00
4,368.00
End Cash Position
25,141.00
29,768.00
41,760.00
89,443.00
6,382.00
Capital Expenditure
-143.00
-422.00
-417.00
-2,324.00
-173.00
Issuance of Capital Stock
20,000.00
--
--
80,106.00
548.00
Issuance of Debt
255.00
1,292.00
--
30,000.00
3,946.00
Free Cash Flow
-28,827.00
-32,692.00
-27,102.00
-22,198.00
-13,074.00
12/31/2020 - 10/28/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
6YG.MU Immunocore Holdings plc
31.40
+2.61%
2L9.SG Blueprint Medicines Corp
107.90
-0.55%
RV7.F Halozyme Therapeutics, Inc.
54.36
+1.27%
LT4.F Liquidia Corporation
13.76
+1.33%
ASEP.CN ASEP Medical Holdings Inc.
0.0650
-13.33%
5CV.F CureVac N.V.
3.6520
-1.78%
TLPPF Telix Pharmaceuticals Limited
17.99
0.00%
SANN.SW Santhera Pharmaceuticals Holding AG
17.12
+4.39%
MRUS Merus N.V.
40.94
-1.52%
GLPG Galapagos NV
23.00
-0.04%